Related Experiment Video
Updated: Jan 6, 2026

10:42
Flow Cytometric Analysis of Particle-bound Bet v 1 Allergen in PM10
Published on: November 19, 2016
7.9K
Could Bet v 1 affect sensitization molecular pattern in children?
Maria Angela Tosca1, Michela Silvestri, Angela Pistorio
1Pediatric Allergy, IRCCS Istituto Giannina Gaslini, Genoa, Italy. gio.cip@libero.it.
Acta Bio-Medica : Atenei Parmensis
|October 4, 2019
Summary
Bet v 1 sensitization impacts allergy profiles in children but doesn't predict clinical outcomes like oral allergy syndrome or anaphylaxis. Further specific IgE testing is recommended alongside molecular diagnostics.
Area of Science:
- Pediatric Allergy
- Immunology
- Molecular Diagnostics
Background:
- Allergy diagnosis relies on identifying specific IgE antibodies.
- Bet v 1, a PR-10 family allergen, is a common sensitizer.
- Pan-allergens can influence allergy testing results.
Purpose of the Study:
- To assess the effect of Bet v 1 sensitization on clinical symptoms in children.
- To correlate Bet v 1 sensitization with oral allergy syndrome (OAS) and anaphylaxis (ANA).
Main Methods:
- Analyzed serum IgE molecular components using the ISAC method.
- Included clinical data from 132 children (91 males, 41 females).
- Mean age of participants was 9.08 years.
Main Results:
- Bet v 1-sensitized children often showed co-sensitization to other PR-10 allergens.
- No significant IgE level differences were found between children with or without food allergy.
- No significant differences in IgE levels were observed between OAS and ANA groups, except for hazelnut allergy.
Conclusions:
- Bet v 1 sensitization affects sensitization patterns in children but doesn't predict clinical presentation.
- The study highlights the need for integrated diagnostic approaches beyond standard molecular allergy testing.
- Specific IgE assays are recommended to complement ISAC testing for precise clinical correlation.
Related Concept Videos
Allergic Reactions
31.9K
Overview
31.9K
Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165

